Bevacizumab for symptomatic radiation-induced tumor enlargement in pediatric low grade gliomas.

about

Treatment of pediatric cerebral radiation necrosis: a systematic review.

P2860

Q38903221-987C5D88-AE24-4073-9AC6-D829915B77AE

P2860

Bevacizumab for symptomatic radiation-induced tumor enlargement in pediatric low grade gliomas.

Item

http://www.wikidata.org/entity/Q38266418

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Bevacizumab for symptomatic ra ...... n pediatric low grade gliomas.

@en

type

Item

label

Bevacizumab for symptomatic ra ...... n pediatric low grade gliomas.

@en

prefLabel

Bevacizumab for symptomatic ra ...... n pediatric low grade gliomas.

@en

P1476

Bevacizumab for symptomatic ra ...... n pediatric low grade gliomas.

@en

P2093

Ian F Pollack

http://www.w3.org/2001/XMLSchema#string

Kimberly A Foster

http://www.w3.org/2001/XMLSchema#string

Regina I Jakacki

http://www.w3.org/2001/XMLSchema#string

William J Ares

http://www.w3.org/2001/XMLSchema#string

P2860

Hypoxia and hypoxia-inducible factor-1 target genes in central nervous system radiation injury: a role for vascular endothelial growth factor

CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006-2010.

Differentiation of true progression from pseudoprogression in glioblastoma treated with radiation therapy and concomitant temozolomide: comparison study of standard and high-b-value diffusion-weighted imaging.

Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas.

Late effects of conformal radiation therapy for pediatric patients with low-grade glioma: prospective evaluation of cognitive, endocrine, and hearing deficits.

Effects of radiation on cerebral vasculature: a review.

Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system.

Bevacizumab as therapy for radiation necrosis in four children with pontine gliomas.

Phase II TPDCV protocol for pediatric low-grade hypothalamic/chiasmatic gliomas: 15-year update.

P304

240-245

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PBC.25277

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-11-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25382690

http://www.w3.org/2001/XMLSchema#string

P921

bevacizumab

Bevacizumab for symptomatic radiation-induced tumor enlargement in pediatric low grade gliomas.

about

P2860

P2860

Bevacizumab for symptomatic radiation-induced tumor enlargement in pediatric low grade gliomas.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921